Several new drugs for the treatment of three types of cancer have been approved for inclusion in the National Health Insurance (NHI) program, which is expected to reduce the financial burden on some 1,000 patients per year and increase their life expectancy, Taiwan's government said Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Taiwan congratulates ally SVG's newly-elected leader, parliament members
11/28/2025 09:52 PM - Politics
Taiwan's envoy thanks Japan for recognizing Taiwan-China differences
11/28/2025 09:33 PM - Business
Taiwan revises 2025 growth forecast to 7.37%, on rising AI demand
11/28/2025 09:21 PM - Cross-Strait
- Society
2 migrant workers arrested on suspicion of selling dog meat in Hsinchu
11/28/2025 07:52 PM